Navigation Links
Interferon does not slow or stop hepatitis C from worsening, study finds
Date:11/9/2007

Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who havent responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found.

Patients in the trial who were treated with interferon did experience a significant decrease in viral levels and liver inflammation, but the trial unequivocally demonstrated that treatment with long-term pegylated interferon also called peginterferon does not prevent the worsening of liver disease in patients whove failed prior treatments.

The results are this study are very clear long-term therapy with peginterferon for those with chronic hepatitis C is not effective in preventing progression of liver disease for patients who did not respond to an initial course of treatment, said Adrian Di Bisceglie, M.D., professor of internal medicine at Saint Louis University School of Medicine and chairman of the trials steering committee.

Furthermore, the relatively high rate of liver disease progression about 30 percent over nearly four years indicates the potential severity of chronic hepatitis C and emphasizes the importance of the ongoing search for new and more effective treatments, Di Bisceglie added.

Results of the study were reported by Di Bisceglie at the annual meeting of the American Association for the Study of Liver Disease in Boston this week.

Hepatitis C infects more than 100 million people worldwide and as many as 4 million people in the U.S. It ranks with alcohol abuse as the most common cause of chronic liver disease and leads to some 1,000 liver transplants in the U.S. each year.

The randomized, multi-site study involved 1,050 patients with chronic hepatitis C whod failed prior treatments to eradicate the infection. All had advanced liver fibrosis a gradual scarring of the liver that puts patients at risk for progress
'/>"/>

Contact: Donn Walker
dwalke18@slu.edu
314-977-8015
Saint Louis University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
2. Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C
3. Stanford researchers find way to fight treacherous hepatitis B
4. Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia
5. Hepatitis A Vaccine Best Bet to Treat Virus
6. Hepatitis C Testing Recommended for Anyone with a Tattoo
7. Is it pancreatitis in acute abdominal pain in acute viral hepatitis?
8. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
9. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
10. Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
11. HGS announces results of Phase 2B trial of Albuferon for chronic hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ut as pandemic seems to ebb, CDC notes a rise in c...Nov. 30 (HealthDay News) -- U.S. health officials... to be on the wane nationally, even as the number ...ues to rise. , The latest report, released Mond...vention (CDC), finds that "visits to doctors for i...
(Date:11/30/2009)..., , Sponsored by Merck, the unique onlin...articipants in their HIV treatment decisions ,.../ -- TheBody ( www.thebody.com ), the #1 HIV/AIDS ... an online and mobile tool offering HIV/AIDS-infec...e their medical data. The tool, created with spons...
(Date:11/30/2009)..., , Study Uses Tent To..., NEW YORK, Nov. 30 Dis...oxygen levels are known to improve their performan...Can heart failure patients, who suffer from fatigu...n a tent-like, high-altitude simulator? ,, That...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ -...d States who are living with HIV/AIDS, nearly half...ction rates in Washington, D.C. have surpassed the...and Black women account for more than 90 percent o...s capitol. On Tuesday, December 1 at 6:00 p.m.*, W...
(Date:11/30/2009)... There is a tiny period of time between the regist...d and our conscious recognition of it ― betw...nize it as an apple. Our minds lag behind our eyes...actions to the world around us? , Some estimat... others say 500 milliseconds. A new study by Tel A...
Breaking Medicine News(10 mins):Health News:U.S. Swine Flu Cases Chart Sharp Decline 2Health News:U.S. Swine Flu Cases Chart Sharp Decline 3Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2
... Gordon, M.D. Will Teach an Innovative Educational...to premiere on Tuesday, November 18th at 8:30 PM E...etworking site afterwards , ...ur part online series on treating depression with ...
...amine Cut Prices, According To New Data ...N, Penn., Oct. 30 Arlington Medical Resources,(AM...the pharmaceutical and,diagnostic imaging industri...time period compared to 9 percent in the January,-...
...Residents to Eat Right, Move More and ... The last decade can be defined by the,ups and do...and out of,fashion like shoulder pads and hemlines... campaign crossing the country, the Campaign for H...
...re,Management Group, Inc. (Phyhealth) (Pink Sheets...ations (HMOs) in partnership with physicians,today...d a stock buyback,program to purchase up to 5% of ...ny,s discretion and can begin 24,hours after the r...
...tility Association,introduces Manicures and Martin... brings young women together in a casual setting o... and don,ts" of preserving fertility. It,s,free, r...ncluding Jamie Grifo, MD, Ph.D., of NYU School of ...
... Reduces Dust by Half While Helping to ...LER, Texas, Oct. 30 New studies conducted by,Envi...fessors at the,Harvard School of Public Health sho... can dust less and have a,healthier, cleaner home ...
Other Medicine News:Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 2Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 3Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 4Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 5Health News:Integrative Medicine Pioneer To Host Free Groundbreaking Web Series on a Natural Approach for Treating Depression 6Health News:Echinocandins Show Growth Among All Antifungal Classes 2Health News:Echinocandins Show Growth Among All Antifungal Classes 3Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Message to Georgia Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 4Health News:Phyhealth Announces Stock Buyback Program 2Health News:Phyhealth Announces Stock Buyback Program 3Health News:The American Fertility Association Announces Plan to Help Young Women Preserve Fertility 2Health News:Studies Reveal Every Homeowner's Dream: You Can Dust Less and Have a Healthier, Cleaner Home 2Health News:Studies Reveal Every Homeowner's Dream: You Can Dust Less and Have a Healthier, Cleaner Home 3
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Min...ing more costly open surgery, particularly in onco... With a global market for image-guided navigation ... are embracing the advantages offered by minimally...covery times, greater patient comfort and faster p...
(Date:11/30/2009)..., , TEL AVIV, Israel, November 30 /PR...ity of the FOMRI-III(TM) dual channel microphone, ... use in functional magnetic resonance imaging,(fMR...OMRI represents a major step forward for fiber,opt...peech quality ever, with,low-latency adaptive nois...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 Stem...biopharmaceutical company and leading developer of... today announced that The University of Texas M.D.... have entered into a research collaboration. As pa... an ongoing Phase I/II clinical trial of SL-401 in...
Breaking Medicine Technology:Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center 2Shamir Optical Industry Ltd Announces Availability of Its Annual Report on Form 20 F Through Its Website 12691 1Shamir Optical Industry Ltd Announces Availability of Its Annual Report on Form 20 F Through Its Website 12691 2Hysterectomies Could Be Source of Stem Cells 49337 1Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 1Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 2Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 3Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 4Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 5Video 3A New Biological Therapy Ilaris 28R 29 Approved in US to Treat Children and Adults with CAPS a Serious Life Long Auto Inflammatory Disease 49334 6
... Phase II GBM study presented at ASCO with cediran...over a quarter of patients alive,and progression- ...ewswire/ -- Data for the,investigational agent ced...l meeting of the American Society of Clinical Onco...t glioblastoma (GBM),an invasive form of brain tu...
... CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmit...II studies of pazopanib in,advanced or metastatic ...t tissue sarcoma (STS). These trials were presente...ty of Clinical Oncology,(ASCO) in Chicago. The res...rt further investigations. , Pazopanib is an oral,...
Other Medicine Technology:Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7
UroPass® II Open Tip Ureteral Stents
...atient position during surgery is key to both the ...ry patient is able to maintain position on their o...ure or necessitate discontinuing treatment to repo...zer eliminates the "drifting that occurs during su...
Pathfinder Chlamydia Culture Confirmation Test
... IgG antibody in women prior to conception provide...lla viral infection during pregnancy. Aggressive ...duced the incidence of rubella epidemics, but a ne...status, especially for women of child-bearing age....
Medicine Products: